Inhibrx, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 1.63 million compared to USD 0.274 million a year ago. Net loss was USD 93.6 million compared to USD 40.92 million a year ago.

Basic loss per share from continuing operations was USD 1.73 compared to USD 0.95 a year ago.